Perla R. Colunga‐Pedraza

Danazol as first-line therapy for aplastic anemia

José Carlos Jaime‐Pérez, Perla R. Colunga‐Pedraza, Cynthia D. Gómez-Ramírez et al. · Annals of Hematology · 2011 · 70 citations

Hematological Malignancy, Bone Marrow Failure, Pharmacology +4

Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplant

José Carlos Jaime‐Pérez, Perla R. Colunga‐Pedraza, Balbina Gutiérrez-Gurrola et al. · Blood Cells Molecules and Diseases · 2013 · 32 citations

Obesity, Bariatric Surgery, Transplantation +11

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Safe and Feasible

Perla R. Colunga‐Pedraza, Andrés Gómez‐De León, Carlos Saúl Rodríguez-Roque et al. · Transplantation and Cellular Therapy · 2020 · 26 citations

More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura

Alberto Vázquez-Mellado, Myrna Pequeño-Luévano, Olga Graciela Cantú‐Rodríguez et al. · Hematology · 2016 · 25 citations · Full text

Danazol as First-Line Therapy for Myelodysplastic Syndrome

Perla R. Colunga‐Pedraza, Julia E. Colunga‐Pedraza, María Alejandra Garza-Ledezma et al. · Clinical Lymphoma Myeloma & Leukemia · 2017 · 24 citations

Hematological Malignancy, First-line Therapy, Oncology +4